Cetera Advisor Networks’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,873
Closed -$267K 2215
2021
Q4
$267K Sell
2,873
-2,550
-47% -$168K ﹤0.01% 1690
2021
Q3
$323K Buy
+5,423
New +$320K ﹤0.01% 1483
2020
Q3
Sell
-371
Closed -$23K 3307
2020
Q2
$23K Buy
+371
New +$20.4K ﹤0.01% 2335

Cetera Advisor Networks's ARNA Position: Q1 2022 in Review

Cetera Advisor Networks sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 2,873 shares — an estimated $267K sold.

Cetera Advisor Networks first reported a position in ARNA in Q2 2020 and held it in 3 quarters. The position peaked at $323K in Q3 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Cetera Advisor Networks reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Cetera Advisor Networks sold 2,873 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $267K.
  • Cetera Advisor Networks first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 3 quarters.
  • Cetera Advisor Networks's Arena Pharmaceuticals Inc position peaked at $323K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Cetera Advisor Networks's 13F filing for Q1 2022, filed 12 May 2022.